FIGURE 2.
Case-mix of hepatocellular carcinoma (HCC) with various dual-tracer positron emission tomography (PET) profiles. The PET part of the non-contrast-enhanced PET/computed tomography (CT) data 18F fluorodeoxyglucose (18F-FDG on the left panel and 18F-choline on the right panel) of three HCCs (A–C) were retrospectively fused to their available contrast-enhanced MRI data (axial T1-weighted MRI pulse sequences with arterial phase contrast enhancement). (A) Dual-PET radiotracers negative uptake (HCC Grade III, with mVI). (B) Dual-PET radiotracers positive uptake (HCC Grade I, with mVI). (C) Negative 18F-FDG uptake but positive 18F-choline uptake (HCC Grade I-II, without mVI).